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Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81 A57knees but have signiﬁcant underlying skeletal defects including thinner
bones that spontaneously fracture. The purpose of this study was to
deﬁne the role of BMP2 in the formation and maintenance of the knee
joint. In order to do this, we removed BMP2 speciﬁcally from synovial
joint cells using the Gdf5-cre transgene.
Methods:We generated BMP2 loss of function conditional mutant mice
using BMP2 ﬂoxed alleles. The Gdf5-cre transgene was used to specif-
ically delete BMP2 within synovial joints (BMP2-Gdf5 cKO) starting at
embryonic day 12.5 (E12.5). We performed histology, immunohis-
tochemistry (IHC), qRT-PCR, Xradia micro-CT, and Atomic Force
Microscopy based (AFM) nanoindentation to assess both molecular and
biomechanical changes in articular cartilage and meniscus during joint
formation, maturation and maintenance using hindlimbs isolated from
E17, 2 week, 8-10 week and 5 month old mice.
Results: Loss of BMP2 from synovial joint forming cells (BMP2-Gdf5
cKO) does not affect knee joint morphogenesis. At E17, the developing
meniscus, ligaments and articular surfaces of the tibia and femur all
appeared normal. At 2 weeks after birth, when joint structures are
maturing, the meniscus of the BMP2-Gdf5 cKO knees appeared devel-
opmentally delayed when compared to controls. Saf-O staining showed
reduced proteoglycan expression as well as decreased rounded chon-
drocyte like cells in BMP2-Gdf5 cKO meniscus. IHC analysis revealed
reduced collagen type 2 (Col2) and altered aggrecan distribution in
BMP2-Gdf5 cKO meniscus while picrosirius red staining showed a
disorganized pattern of collagen ﬁbers. This data was conﬁrmed using
qPCR analysis that showed a decrease in both Col2 and aggrecan
expression in 2 wk old menisci from BMP2-Gdf5 cKO mice compared to
controls and revealed that BMP target genes Lox (lysl oxidase) and
Runx2 were also down regulated. AFM nanoindentation testing of knee
joints of 2 wk old BMP2-Gdf5 and control mice revealed no signiﬁcant
differences in the nanomechanical properties of the articular cartilages.
However, menisci from BMP2-Gdf5 KO mice appeared to have weak-
ened mechanical function with signiﬁcantly lower indentation stiffness
when compared to controls. By 8-10 weeks of age, menisci from BMP2-
Gdf5 cKO knees appeared to be less ossiﬁed and continued to have
decreased expression of ECM components. In addition, knee joints of
the BMP2-Gdf5 cKO mice started to show signs of early OA as the
articular cartilage began to ﬁbrillate. By 5 months of age, Xradia micro-
CT analysis showed loss of BMP2 results in joint space narrowing,
ﬂattened tibial epiphyses, menisci that are smaller and signiﬁcantly less
well mineralized, but no evidence of osteophyte formation. IHC analysis
of 5 month old BMP2-Gdf5 cKO knees revealed distinct signs of pro-
gressive OA pathology including decreased expression of Col2, aggrecan
and pSmad2 and increased expression of collagen type X (ColX) and
ADAMTS5 when compared to controls.
Conclusions: BMP signaling provided by BMP2 is not required for knee
joint formation during development but is necessary for the main-
tenance of knee joint function after birth. Our ﬁndings reveal an
important role for BMP2 in the proper assembly and maturation of the
meniscus ECM that appears to be essential for joint homeostasis as mice
lacking BMP2 in Gdf5 þ cells develop spontaneous OA as they age. Our
data point to an important role for BMP2 production by cells in the knee
joint and suggest that interventions that allow for the maintenance of
adequate local BMP2 expression by these structuresmay be of beneﬁt in
the prevention of age related knee OA.
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Purpose: The mechanisms which govern osteoblast-to-osteocyte
transitions (osteocytogenesis) are yet to be established, however their
dysregulation is likely to contribute to osteoarthritic (OA) subchondral
bone sclerosis. The transmembrane glycoprotein E11 is critical in early
osteocyte commitment thus here we sought to determine the mecha-
nism regulating its expression during osteocytogenesis and to examine
whether this was compromised in OA.
Methods:We have used immunohistochemistry, RT-qPCR and western
blotting to examine the temporal and spatial localisation of E11 duringosteocytogenesis. To examine the functional role of E11 we transfected
the late osteoblast MLO-A5 cell line with E11 over-expressing and
empty vector pLVX plasmids using Fugene HD. Using these cells we
have investigated the post-translational regulation of E11, through
addition of calpain and proteasome inhibitors (Z-FA-FMK, E64d, cal-
peptin, ALLN and MG132, lactacystin, Bortezomib, Withaferin-A,
respectively) and subsequent western blotting and RT-qPCR analysis.
We have generatedmice harbouring a conditional deletion of E11 in late
osteoblasts (osteocalcin promoter driven) (OB-E11-/-) and analysed its
bone phenotype through histology, RT-qPCR and micro-CT scanning.
We have also examined the natural OA model, the STR/Ort mouse, with
regards to E11 expression.
Results: We reveal increased expression of E11 protein/mRNA
(P<0.001) concomitant with extensive osteocyte dendrite formation
and matrix mineralization (P<0.001) in MLO-A5 cell cultures. Whilst
MLO-A5 cells transfected with E11 over-expressing pLVX plasmids
exhibited signiﬁcantly increased mRNA expression (P<0.001), western-
blotting failed to detect any correlative increases in protein expression,
suggestive of post-translational regulation. We therefore treated MLO-
A5 cells with calpeptin and ALLN and found that both promoted E11
protein expression, with ALLN having the greatest effect. Treatment of
MLO-A5 cells and osteocytic IDG-SW3 cells with ALLN also induced a
profound increase in stellate cell morphology (50%, P<0.001) and
increased E11 protein expression, whilst calpeptin treatment failed to
promote similar osteocytogenic changes. Alternative calpain inhibitors
E64d and Z-FA-FMK also failed to modify MLO-A5 cell morphology or
E11 protein expression. Unchanging calpain 1/2 levels upon osteocytic
differentiation during 15-day MLO-A5 time course suggests lack of
calpain contribution to osteocytogenesis. Due to the dual roles for ALLN
in calpain and proteasome inhibition, this characterized proteasomal
degradation as the key pathway in E11 post-translational targeting and
degradation. This was supported by studies using the proteasome
inhibitors MG132, lactacystin, Bortezomib and Withaferin-A which
produced similar dose-dependent increases in E11 expression in MLO-
A5 cells. These data implicate proteasome degradation in controlling
E11 stability. Preliminary microCT analyses of OB-E11-/- mice revealed
decreased trabecular bone volume/tissue volume (27%) associated with
decreased trabecular number (16%) and thickness (7%) in comparison to
control mice. This pilot data has also revealed that the conditional
deletion of E11 in osteoblasts results in decreased cortical cross-sec-
tional thickness (12%). Further analyses will enable a more thorough
skeletal phenotyping of these mice which will include osteocyte
number and dendrite formation. Examination of a natural model of OA,
the STR/Ort mouse, revealed decreased E11 protein expression in the
subchondral bone osteocytes in regions of the joint where OA pathology
is observed.
Conclusions: Together these data suggest that proteasome-mediated
E11 protein degradation limits acquisition of the osteocyte phenotype
and that its deregulation may contribute to bone changes observed in
OA.
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Purpose: Femoroacetabular impingement (FAI) is a cause of pain and
osteoarthritis. The pathogenesis of this condition remains poorly
understood and this limits the ability to develop treatment strategies.
Cam morphology is thought to develop during adolescence, often in
association with intense sporting activity. Postulated mechanisms
include a subclinical slipped upper femoral epiphysis (SUFE) or
extension of the epiphysis along the anterosuperior femoral neck. Cam
morphology has an extremely high prevalence amongst professional
footballers making them an ideal cohort to study disease
pathogenesis.
Methods: Players at an English Premiership Football (Soccer) Club
Academy were invited to participate using a randomisation algorithm
within each age group. The cross-sectional cohort was loaded towards
the youngest age groups to enhance a future longitudinal study. 20
players were selected from the U10 and U11 teams, and 10 players
from the U12, U13, U14, U15, U16, and U18 teams (n¼100).
